735 related articles for article (PubMed ID: 32006212)
1. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
2. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
Mishima Y; Sartor RB
J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
[TBL] [Abstract][Full Text] [Related]
3. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Lee M; Chang EB
Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
6. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S; Dhaneshwar S
World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
8. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
10. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
[TBL] [Abstract][Full Text] [Related]
11. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
[TBL] [Abstract][Full Text] [Related]
12. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
13. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
14. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
[TBL] [Abstract][Full Text] [Related]
16. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics, probiotics and prebiotics in IBD.
Bernstein CN
Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
[TBL] [Abstract][Full Text] [Related]
19. Current and future microbiome-based therapies in inflammatory bowel disease.
Montrose JA; Kurada S; Fischer M
Curr Opin Gastroenterol; 2024 Jul; 40(4):258-267. PubMed ID: 38841848
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ
World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]